Drreddys Laboratories | RDY - Pre Tax Profit


Drreddys Laboratories reported INR2B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 40.22M 8.74M Mar/2026
Aurora Cannabis CAD 11.41M 12.99M Mar/2026
Bayer EUR 2.99B 6.36B Mar/2026
Canopy Growth CAD -157.96M 95.71M Mar/2026
Cipla INR 10.82B 3.33B Jun/2026
Corcept Therapeutics USD -44.72M 54.62M Mar/2026
Drreddys Laboratories INR 2B 13.43B Mar/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Novartis USD 4.27B 430M Jun/2026
Pacira USD 5M 4.43M Mar/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 64.77M 2.96M Mar/2026
Richter Gedeon HUF 78.56B 32.66B Dec/2024
Sun Pharmaceuticals INR 35.51B 6.76B Mar/2026
Supernus Pharmaceuticals USD -57.65M 51.7M Jun/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026